Impact of fatigue on the efficacy of rehabilitation in multiple sclerosis.
Fatigue is considered to be one of the most common and disabling symptoms among individuals with multiple sclerosis (MS). The aim of this study is to investigate if an intensive, short-term inpatient rehabilitation program is able to improve fatigue in MS, and if fatigue is able to negatively influence the clinical and functional outcome of rehabilitation in MS. One-hundred eighty six consecutively recruited MS patients underwent an intensive, short-term inpatient rehabilitation program. Sixty-four of them were selected for this study according to our inclusion criteria and compared to a control group of 22 MS patients who did not follow a rehabilitation program. We measured fatigue symptoms with the Fatigue Severity Scale (FSS) before and after rehabilitation, and classified patients into fatigued (FMS) in the case of an FSS score ≥36 and into non-fatigued MS (NFMS) in the case of an FSS <36. Expanded Disability Status Scale (EDSS) and Functional Independence Measure (FIM) were used as clinical outcome measures of the efficacy of the rehabilitation program. In our sample, an intensive, short-term rehabilitation treatment is able to determine a significant reduction of fatigue symptoms compared to untreated MS patients (p < 0.0001); however, the presence of fatigue at the beginning of the rehab program seems not to have any impact on the clinical and functional outcome of rehabilitation. An intensive inpatient rehabilitation trial decreases symptom of fatigue in MS patients; furthermore fatigue seems not to modify the amelioration of disability and impairment determined by a rehabilitation program.
Neurorehabilitation Unit, Department of Neurology, Institute of Experimental Neurology, Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy.
Elda
E
Judica
Filippo
F
Martinelli Boneschi
Daniela
D
Ungaro
Mauro
M
Comola
Roberto
R
Gatti
Giancarlo
G
Comi
Paolo
P
Rossi
D000328:Adult; D005221:Fatigue / Q000209:etiology / Q000534:rehabilitation*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000150:complications / Q000534:rehabilitation*; D012720:Severity of Illness Index; D016896:Treatment Outcome
Arch Phys Med Rehabil. 1984 Mar;65(3):135-8
6703889
Neuroimage. 2001 Jun;13(6 Pt 1):1186-92
11352624
Arch Neurol. 1988 Apr;45(4):435-7
3355400
Mult Scler. 2000 Apr;6(2):124-30
10773859
Neurorehabil Neural Repair. 2008 Jan-Feb;22(1):91-100
17409388
Neurology. 2004 Jun 8;62(11):2058-64
15184614
Neurology. 1996 Apr;46(4):907-11
8780061
Psychosom Med. 2003 Jul-Aug;65(4):542-7
12883103
Brain. 1999 Jan;122 ( Pt 1):141-59
10050902
J Psychosom Res. 1998 Dec;45(6):507-17
9859853
J Neurol Sci. 2006 Apr 15;243(1-2):39-45
16434057
J Neurol. 2002 May;249(5):535-7
12021941
Int J Nurs Pract. 2008 Apr;14(2):81-93
18315820
Arch Neurol. 1996 Jul;53(7):642-9
8929171
Arch Clin Neuropsychol. 2006 Jan;21(1):53-76
16290063
J Neurol. 2000 Jul;247(7):506-9
10993490
Neurology. 1995 Nov;45(11):1956-61
7501140
Brain. 1999 May;122 ( Pt 5):871-82
10355672
Mult Scler. 2000 Jun;6(3):181-5
10871830
Mult Scler. 2005 Oct;11(5):592-601
16193899
Med Sci Sports Exerc. 1993 Apr;25(4):451-65
8479299
Funct Neurol. 1997 Sep-Oct;12(5):247-51
9439942
J Sports Med Phys Fitness. 2001 Dec;41(4):421-32
11687760
Arch Neurol. 1989 Oct;46(10):1121-3
2803071
J Neurol. 2009 Apr;256(4):645-50
19367356
Neurology. 1983 Nov;33(11):1444-52
6685237
Ann Neurol. 2001 Jul;50(1):121-7
11456302
Can J Neurol Sci. 1994 Feb;21(1):9-14
8180914
Disabil Rehabil. 2009;31(9):685-92
18841515
Int MS J. 2007 Jun;14(2):64-71
17686346
Disabil Rehabil. 2008;30(19):1480-5
19230218
Neurol Sci. 2008 Sep;29 Suppl 2:S241-3
18690505
J Neurol. 2002 Aug;249(8):1027-33
12195449